The necessity of GlyRS binding NRP1 for the disease mechanism leading to neuropathy is called into question by the failure of NRP1 to bind ΔETAQ, a four amino acid internal deletion in GlyRS that causes a severe, early onset neuropathy in both mice and humans (Morelli et al., 2019). Here, GARS1 is linked to neuropathy.